Skip to main content

Table 3 Summary of findings in included sepsis studies (n = 10)

From: Association between intravenous fluid administration and endothelial glycocalyx shedding in humans: a systematic review

References

Intervention/exposure

Group size, n

Fluid volume (mL) at t = 24 h

Glycocalyx measure(s)

Summary of study findings

Macdonald et al. [33]

Standard fluid regime

49

3550 (2750,4410)a,c,d

Syn-1, Syn-4, HS, hyaluronan; t = 0 h, t = 3 h, t = 6 h, t = 24 h

No consistent relationship was found between fluid administration and glycocalyx markers. Syn-4 and hyaluronan showed greater or contrasting downward pattern in the restricted fluid group compared to standard. No differences were noted for Syn-1 or HS

Restricted fluid regime

46

4360 (3350,5252)a,c,d

Ilyina [34]

Crystalloid fluid bolus (7 mL/kg)

18

3560, 1870b

Syn-1, HS; t = 0 h, t = 2 h, t = 24 h

There was no significant change in Syn-1 or HS at any time point after fluid loading

Macdonald [32, 33]

Total fluid administration

86

4073, 2507a

Syn-1, Syn-4, hyaluronan; t = 0 h, t = 24 h

There was no significant relationship between cumulative fluid administration and glycocalyx markers, adjusted for age, sex, mean arterial pressure, lactate, CCI, SOFA score, infection source, and recruitment site

Saoraya [31]

Standard fluid rate (30 mL/kg/h)

49

3758 (1237,4975)b,c,d

Syn-1; t = 0 h, t = 6 h

There was no significant intergroup difference in Syn-1 over time, before and after adjusting for hemodynamic status and vasopressor use. There was no significant intra-group change in Syn-1 during the intervention

Limited fluid rate (10 mL/kg/h)

49

2896 (1520,4535)b,c,d

Hippensteel [30]

Total fluid administration

56

–

Syn-1, HS; t = 0 h, t = 6 h

Heparan sulfate concentration was significantly associated with cumulative fluid administration, after adjusting for age and sepsis severity (p = 0.047)

Hippensteel [30]

Total fluid administration

100

1681, 1801a

HS; t = 0 h, t = 24 h

Each 1L of administered fluid over 24 h was associated with a 200 ng/mL increase in heparan sulfate, after adjusting for age and sepsis severity (p = 0.006)

Inkinen [29]

Total fluid administration

619

5928 (4152,8712)a,c

Syn-1; t = 0 h, t = 24 h, t = 120 h

There was no significant relationship between Syn-1 and tertile of cumulative fluid administration

Pouska et al. [36]

Fast fluid bolus

25

–

PBR; t = 0 h, t = 1 h, t = 2 h

There were no significant intergroup differences at any time point after fluid bolus. No significant temporal change in PBR was observed in the general cohort

Slow fluid bolus

9

–

Smart [35]

10 ml/kg 0.9% NaCl

 

2000 (1000, 2500)a,c

Syn-1, hyaluronan; t = 0 h, t = 1 h, t = 3 h, t = 24 h

Significant fold-change in Syn-1 T0 to T1 in isotonic group corresponding with larger fluid volume in this period. No overall difference in biomarkers or fluid volume at 24 h. Low illness severity and majority patients had simple infection not sepsis

5 ml/kg 3% NaCl

 

1500 (500–2500)a,c

Smart [28]

Total fluid administration

86

3701 (2225,4750)a,c

Syn-1, Syn-4, hyaluronan; t = 0 h, t = 1–2 h, t = 3–5 h, t = 12–24 h

Each 1L of administered fluid was associated with a 22% increase in hyaluronan at t = 0 h, adjusted for infection severity and cytokine response (p = 0.001). This remained significant at t = 1–2 h and t = 3–5, but not at t = 12–24. No associations were noted for Syn-1 or Syn-4

Wu [27]

Total fluid administration

15

1616, 1113b

Syn-1; t = 0 h, t = 3 h, t = 6 h, t = 24 h, t = 48 h

Syn-1 levels were highly correlated with corresponding fluid balance at each of the four time points (p = 0.026)

  1. CCI Charlson Co-morbidity Index, HS heparan sulfate, PBR perfused boundary region, SOFA Sequential Organ Failure Assessment, Syn syndecan, Syn-1 syndecan-1, Syn-4 syndecan-4
  2. aFluid volume reported as total fluid administered
  3. bFluid volume reported as fluid balance at t = 24 h
  4. cValue reported as median (interquartile range)
  5. dSignificant difference between intervention/exposure groups